berdazimer sodium (SB204)
/ Sato Pharma, Novan Research & Development
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 03, 2026
Nitric Oxide-releasing Topical Gel for the Management of Moderate-to-severe Acne Vulgaris: A Meta-analysis.
(AAD 2026)
- "In brief, the 4% nitric oxide-releasing topical gel effectively reduces acne lesions in adults with acne vulgaris, displaying promise despite limited IGA improvement. Safety analysis indicates a modestly increased pain incidence, with dryness and erythema similar to placebo, implying an overall favorable safety profile, necessitating further comprehensive research for confirmation. Key words: Acne Vulgaris, Acne, Nitric Oxide, Berdazimer, SB-204, NVN100."
Retrospective data • Acne Vulgaris • Dermatology • Inflammation
May 28, 2020
Dr Marc Matrana SB 204
(YouTube)
- "Dr. Marc Matrana spoke with the Louisiana House Insurance Comittee on Wednesday to explain the applications of SB 204 in the medical field."
Video
1 to 2
Of
2
Go to page
1